SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

WFRF:(Kaderi Mohd Arifin)
 

Search: WFRF:(Kaderi Mohd Arifin) > Linderholm Mats > MDM2 promotor polym...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia : results of an individual patient data-based meta-analysis

Benner, Axel (author)
German Cancer Research Centre, Germany
Mansouri, Larry (author)
Uppsala universitet,Hematologi och immunologi,Uppsala University, Sweden
Rossi, Davide (author)
Amedeo Avogadro University of Eastern Piedmont, Italy
show more...
Majid, Aneela (author)
University of Leicester, England
Willander, Kerstin (author)
Östergötlands Läns Landsting,Linköpings universitet,Avdelningen för cellbiologi,Hälsouniversitetet,Hematologiska kliniken US
Parker, Anton (author)
Royal Bournemouth Hospital, England
Bond, Gareth (author)
University of Oxford, England
Pavlova, Sarka (author)
Masaryk University, Czech Republic; Masaryk University, Czech Republic
Nueckel, Holger (author)
University of Duisburg Essen, Germany
Merkel, Olaf (author)
Paracelus Medical University, Austria
Ghia, Paolo (author)
University of Bita Salute San Raffaele, Italy
Montserrat, Emili (author)
University of Barcelona, Spain
Kaderi, Mohd Arifin (author)
Uppsala universitet,Hematologi och immunologi,Uppsala University, Sweden; Int Islamic University of Malaysia, Malaysia
Rosenquist, Richard (author)
Uppsala University, Sweden
Gaidano, Gianluca (author)
Amedeo Avogadro University of Eastern Piedmont, Italy
Dyer, Martin J. S. (author)
University of Leicester, England,University of Ulm, Germany
Söderkvist, Peter (author)
Östergötlands Läns Landsting,Linköpings universitet,Avdelningen för cellbiologi,Hälsouniversitetet,Klinisk patologi och klinisk genetik
Linderholm, Mats (author)
Linköpings universitet,Institutionen för klinisk och experimentell medicin,Hälsouniversitetet
Oscier, David (author)
Royal Bournemouth Hospital, England
Tvaruzkova, Zuzana (author)
Masaryk University, Czech Republic; Masaryk University, Czech Republic
Pospisilova, Sarka (author)
Masaryk University, Czech Republic; Masaryk University, Czech Republic
Duehrsen, Ulrich (author)
University of Duisburg Essen, Germany
Greil, Richard (author)
Paracelus Medical University, Austria
Doehner, Hartmut (author)
University of Ulm, Germany
Stilgenbauer, Stephan (author)
Zenz, Thorsten (author)
German Cancer Research Centre, Germany; University of Heidelberg Hospital, Germany
show less...
 (creator_code:org_t)
2014-07-31
2014
English.
In: Haematologica. - : Ferrata Storti Foundation (Haematologica). - 0390-6078 .- 1592-8721. ; 99:8, s. 1285-1291
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • A number of single nucleotide polymorphisms have been associated with disease predisposition in chronic lymphocytic leukemia. A single nucleotide polymorphism in the MDM2 promotor region, MDM2SNP309, was shown to soothe the p53 pathway. In the current study, we aimed to clarify the effect of the MDM2SNP309 on chronic lymphocytic leukemia characteristics and outcome. We performed a meta-analysis of data from 2598 individual patients from 10 different cohorts. Patients' data and genetic analysis for MDM2SNP309 genotype, immunoglobulin heavy chain variable region mutation status and fluorescence in situ hybridization results were collected. There were no differences in overall survival based on the polymorphism (log rank test, stratified by study cohort; P=0.76; GG genotype: cohort-adjusted median overall survival of 151 months; TG: 153 months; TT: 149 months). In a multivariable Cox proportional hazards regression analysis, advanced age, male sex and unmutated immunoglobulin heavy chain variable region genes were associated with inferior survival, but not the MDM2 genotype. The MDM2SNP309 is unlikely to influence disease characteristics and prognosis in chronic lymphocytic leukemia. Studies investigating the impact of individual single nucleotide polymorphisms on prognosis are often controversial. This may be due to selection bias and small sample size. A meta-analysis based on individual patient data provides a reasonable strategy for prognostic factor analyses in the case of small individual studies. Individual patient data-based meta-analysis can, therefore, be a powerful tool to assess genetic risk factors in the absence of large studies.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Hematologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Hematology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view